Biofeedback-VR for Treatment of Chronic Migraine

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 9, 2020

Primary Completion Date

April 1, 2021

Study Completion Date

March 1, 2022

Conditions
Chronic MigraineBehavioral TreatmentBiofeedbackVirtual RealityMedication Overuse Headache
Interventions
DEVICE

Combined biofeedback-virtual reality device

The study's biofeedback-VR device was developed in collaboration with students and faculty at the University of Washington Global Innovation Exchange program. The system included an Oculus Go mobile VR headset (wireless, portable, head-mounted display, with screen providing a 101° field of view with 2560 x 1440 resolution at a 60-72 Hz frame rate; Oculus VR, LLC, Menlo Park, CA/USA) and with built-in speaker, in addition to a Polar H10 heart rate monitor (electrocardiogram, or ECG, to measure heart rate; Polar Electro Inc., Bethpage, NY/USA), with customized software programmed for the study using the Unity3D game engine (Unity Technologies, Bellevue, WA/USA). Individuals in the experimental arm are asked to use this device for 10 minutes daily, on at least 3 days per week.

Trial Locations (1)

98105

University of Washington, Seattle

All Listed Sponsors
collaborator

University of California, San Francisco

OTHER

lead

University of Washington

OTHER

NCT05720819 - Biofeedback-VR for Treatment of Chronic Migraine | Biotech Hunter | Biotech Hunter